August 29, 2017

Related Content:

VideosGastrointestinal CancerAdverse Event ManagementNurse Navigation
Individualized Treatment May Improve Outcomes in Gastroesophageal Cancer
FDA Approves Frontline Pembrolizumab for HER2+ Gastric, GEJ Cancer
Factors Correspond With Higher Levels of Sleep Disturbance in Patients with GI Cancers